Undervalued RWA project on @base On @base, DeSci is still a wide open lane. Most attention and liquidity have gone to other narratives, while there is still no clear infrastructure that consistently brings real scientific IP onchain. That is exactly why I have been watching @OrigodotFun closely as a DeSci native stack that wants to make Base the home for tokenized science and medical RWA, not just another rotating speculation. @OrigodotFun solves the biggest pain points in today’s DeSci landscape, liquidity and compliance, and DCPlus is the first real case that proves this model works. Most DeSci projects stop at selling NFTs for ownership, without a real economic loop. Once they touch dividends or profit sharing, they risk securities regulation, blocking compliant capital and leaving users without sustainable positive returns. The core innovation of Origo is replacing “securities dividends” with “market incentives”. Project teams no longer promise profit distribution, but publish an IP Marketing Claim, and Origo runs a blockchain loop of Claim, Injection and Tax. Project revenue is injected into Origo’s incentive system as marketing spend, and token holders receive rewards through the tax mechanism. Legally this is marketing cost; economically it is price support, enabling a long term incentive loop without becoming a security. @dcplus_official, the first genesis project on Origo Hub, the curation launchpad, shows how a real scientific product can move from offline innovation to on-chain assets. With the mangosteen extract and gas controlled patch as its base, DCPlus proves Origo is not an empty narrative, but real infrastructure that can carry tangible medical value and cash flow. On top of that, Origo runs a dual track: https://t.co/zMn2a6x6aA for permissionless traffic, OrigoHub for curated value. $DCPLUS CA：0x10B2cF5A47e9DEA699bd7aCCc88AbBAE269f28f9 DCPlus sits in a huge market, targeting global prescription drugs and health supplements with a clinically supported product built by a Taiwanese biotech team. Users buy physical patches using DCPlus tokens, and those tokens are fully burned, creating a strong deflationary engine. As the first deeply integrated OrigoHub launch, protocol tax incentives flow to liquidity providers, while real world revenue is injected back into Origo modules, giving holders continuous and compliant value support. Today there is a clear mismatch between DCPlus price and fundamentals. Its market cap is around 4 million USD, yet it is OrigoHub’s genesis project with a real medical RWA product and about 1 million USD of liquidity locked for three years on @GoPlusSecurity, a platform backed by @binance. This locked liquidity adds credibility, stabilizes the pool and reduces early sell pressure. When you combine real world revenue, a hard burn model, low market cap and long term locked liquidity, DCPlus starts to look like a heavily underpriced asset with high safety margin and strong certainty, more like a fully built launch pad waiting for time to ignite.